chartexchange

VIR
Vir Biotechnology, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
9.14USD-1.189%(-0.11)2,154,928
Pre-marketNov 18, 2026 9:28:30 AM EST
9.15USD-1.081%(-0.10)
After-hoursNov 18, 2026 4:45:30 PM EST
9.42USD+3.063%(+0.28)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Francisco, CA, USA
Previous Close
$9.25
Beta
1.85
52-Week High
$14.38 2026-11-09
52-Week Low
$5.32 2025-11-19
SMA 50
$11.04
SMA 200
$9.79
Avg. Vol 10D
4.57M
Avg. Vol 30D
2.65M
Avg. Vol 90D
2.16M
Relative Vol
0.81
186.27M
135.70M
16,874,443
0.3300%
2,100,000
147
VIR Profile

vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world's most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.

VIR Performance
PeriodPriceDateChangeBeta
1W12.122026-11-12-24.59%-3.531
1M10.212026-10-19-10.48%2.608
3M9.772026-08-19-6.45%2.563
6M8.532026-05-19+7.15%1.706
1Y5.442025-11-19+68.02%1.853
2Y6.932024-11-19+31.89%—
5Y32.752021-11-19-72.09%1.411
VIR Stock Summary

Vir Biotechnology, Inc. Common Stock (NASDAQ:VIR) stock price today is $9.14, and today's volume is 2,154,928. VIR is down 1.189% today. The 30 day average volume is 2.65M. VIR market cap is $1.70B with 186.27M shares outstanding.